1. |
Rouvier E, Luciani MF, Mattéi MG, et al. CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene. J Immunol, 1993, 150:5445-5456.
|
2. |
Zhu S, Qian Y. IL-17/IL-17 receptor system in autoimmune disease:mechanisms and therapeutic potential. Clin Sci, 2012, 122:487-511.
|
3. |
Aggarwal S, Gurney AL. IL-17:prototype member of an emerging cytokine family. Leukoc Biol, 2002, 71:1-8.
|
4. |
Iwakura Y, Ishigame H, Saijo S, et al. Functional specialization of interleukin-17 family members. Immunity, 2011, 34:149-162.
|
5. |
Ye P, Rodriguez FH, Kanaly S, et al. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. Exp Med, 2001, 194:519-527.
|
6. |
Happel KI, Dubin PJ, Zheng M, et al. Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae. Exp Med, 2005, 202:761-769.
|
7. |
Kudva A, Scheller EV, Robinson KM, et al. Influenza A inhibits Th17-mediated host defense against bacterial pneumonia in mice. J Immunol, 2011, 186:1666-1674.
|
8. |
Chen L, Guo S, Wu L, et al. Effects of recombinant IL-17F intranasal inoculation against Streptococcus pneumoniae infection in a murine model. Biotech Appl Biochem, 2015, 62:393-400.
|
9. |
徐西琳, 熊盛道.表达IL-17的正义质粒对小鼠铜绿假单胞菌肺部感染防御机制的研究[学位论文].武汉华中科技大学, 2011:10-12.
|
10. |
Freches D, Korf H, Denis O, et al. Mice genetically inactivated in interleukin-17A receptor are defective in long-term control of Mycobacterium tuberculosis infection. Immunology, 2013, 140:220-231.
|
11. |
Aujla SJ, Chan YR, Zheng M, et al. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat Med, 2008, 14:275-281.
|
12. |
Khader SA, Bell GK, Pearl JE, et al. IL-23 and IL-17 in the establishment of protective pulmonary CD4+T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol, 2007, 8:369-377.
|
13. |
Zelante T, De Luca A, Bonifazi P, et al. IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur J Immunol, 2007, 37:2695-2706.
|
14. |
Werner JL, Metz AE, Horn D, et al. Requisite role for the dectin-1 β-glucan receptor in pulmonary defense against Aspergillus fumigatus. J Immunol, 2009, 182:4938-4946.
|
15. |
Freeman AF, Kleiner DE, Nadiminti H, et al. Causes of death in hyper-IgE syndrome. Allergy Clin Immunol, 2007, 119:1234-1240.
|
16. |
Hamada H, Garcia-Hernandez Mde L, Reome JB, et al. Tc17, a unique subset of CD8 T cells that can protect against lethal influenza challenge. J Immunol, 2009, 182:3469-3481.
|
17. |
Crowe CR, Chen K, Pociask DA, et al. Critical role of IL-17RA in immunopathology of influenza infection. J Immunol, 2009, 183:5301-5310.
|
18. |
Li C, Yang P, Sun Y, et al. IL-17 response mediates acute lung injury induced by the 2009 pandemic influenza A (H1N1) virus. Cell Res, 2012, 22:528-538.
|
19. |
Li WJ, Moltedo B, Moran TM. Type I interferon induction during influenza virus infection increases susceptibility to secondary Streptococcus pneumoniae infection by negative regulation of γδ T cells. J Virol, 2012, 86:12304-12312.
|
20. |
Didierlaurent A, Goulding J, Patel S, et al. Sustained desensitization to bacterial Toll-like receptor ligands after resolution of respiratory influenza infection. J Exp Med, 2008, 205:323-329.
|
21. |
Robinson KM, Choi SM, McHugh KJ, et al. Influenza A exacerbates Staphylococcus aureus pneumonia by attenuating IL-1β production in mice. J Immunol, 2013, 191:5153-5159.
|
22. |
Wu Q, Martin RJ, Rino JG, et al. IL-23-dependent IL-17 production is essential in neutrophil recruitment and activity in mouse lung defense against respiratory Mycoplasma pneumoniae infection. Microbes Infect, 2007, 9:78-86.
|
23. |
Kurai D, Nakagaki K, Wada H, et al. Mycoplasma pneumoniae extract induces an IL-17-associated inflammatory reaction in murine lung: implication for mycoplasmal pneumonia. Inflammation, 2013, 2:285-292.
|